WO2007097120A1 - 細胞培養構造体、細胞培養容器、スフェロイド付き構造体、スフェロイド付き容器およびこれらの製造方法 - Google Patents
細胞培養構造体、細胞培養容器、スフェロイド付き構造体、スフェロイド付き容器およびこれらの製造方法 Download PDFInfo
- Publication number
- WO2007097120A1 WO2007097120A1 PCT/JP2007/000106 JP2007000106W WO2007097120A1 WO 2007097120 A1 WO2007097120 A1 WO 2007097120A1 JP 2007000106 W JP2007000106 W JP 2007000106W WO 2007097120 A1 WO2007097120 A1 WO 2007097120A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell culture
- cells
- less
- producing
- container
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
- C12N2535/10—Patterned coating
Definitions
- Cell culture structure cell culture container, spheroid structure, spheroid container, and production method thereof
- the present invention relates to a cell culture structure, a cell culture container, a structure with spheroids, a container with spheroids, and a method for producing them.
- spheres which are three-dimensional tissues having functions equivalent to those in vivo
- a plurality of single cells are seeded on a funnel whose bottom surface is a funnel, and the single cells are aggregated and divided on the bottom surface to cultivate the spheroid (Patent Document 1) or a predetermined polymer mixture.
- Patent Document 1 There is a type in which spheroids are cultured on a honeycomb structure obtained by condensing water on the cast liquid surface and evaporating minute water droplets generated by the dew condensation (Patent Document 2).
- Patent Document 1 Japanese Patent Application Laid-Open No. 6_3 2 7 4 6 2 (paragraph number 0 0 1 6, FIG. 1)
- Patent Document 2 Japanese Patent Laid-Open No. 2 0 2 _ 3 3 5 9 4 9 (Page 3, Fig. 1)
- the former does not have a scaffold of spheroids produced by culturing, and the spheroids are difficult to be fixed to a cell culture structure or a cell culture vessel. Therefore, when the medium is changed, the spheroids are lost along with the medium, or
- the operation of exchanging the medium becomes very complicated and it becomes difficult to maintain a good culture environment.
- multiple cells aggregate to form a sphere, even if we try to simulate the dynamics of cancer cells, the characteristics of the tumor formed by dividing one cancer cell in vivo and the sphere Since the nature of this is strictly different, there is a problem that the accuracy of the simulation is lowered.
- the material used for the honeycomb structure is limited, the size of the honeycomb structure cannot be precisely controlled, and the structure has a shape other than the honeycomb structure whose planar shape is a circle.
- problems such as difficulty in making.
- it took a very long time to fabricate the honeycomb structure and there were also problems that the cost was high and it was not suitable for mass production.
- the cells used are cells that can be evaluated even when multiple cells such as hepatocytes cooperate, and are formed by dividing from a single cell in vivo, such as cancer cells. There is no suggestion of evaluation of tumor simulations.
- the cell culture structure of the present invention is characterized by having an uneven structure with an uneven width of 3 m or less.
- another cell culture structure of the present invention is characterized in that the planar shape is polygonal and has a concavo-convex structure in which a plurality of cells having a minimum inner diameter of 3 Um or less are continuously provided. .
- the cell preferably has a hexagonal shape in the planar direction.
- the cell preferably has a maximum inner diameter of 3 m or less. Further, the width between the cells is preferably 3 m or less.
- the cell culture structure is preferably in the form of a fillet.
- the cell culture structure has a small area in the plane direction. It is preferable that the cell is formed to be larger than the area of the bottom surface of a vessel for culturing vesicles, for example, a multiwell plate.
- the cell culture structure is preferably formed of one or more of polystyrene, polyimide, acrylic resin, cyclic olefin-based thermoplastic resin, aluminum oxide, glass, quartz glass, and silicon.
- the method for producing a cell culture structure of the present invention is a method for producing a cell culture structure having a concavo-convex structure, and the width of the concavo-convex is 3 U m or less on a workpiece using nanoimprint technology.
- the concavo-convex structure is formed.
- another method for producing a cell culture structure according to the present invention is a method for producing a cell culture structure having a concavo-convex structure, and the shape to be processed has a large number of planar shapes using a nanoimprint technique.
- the concavo-convex structure is characterized in that a plurality of cells having a rectangular shape and a minimum inner diameter of 3 jum or less are continuously formed.
- the cell preferably has a hexagonal shape in the planar direction.
- the cell preferably has a maximum inner diameter of 3 m or less.
- the width between the cells is preferably 3 m or less.
- the object to be processed is preferably in the shape of a fillet.
- the processing object has a larger area in the plane direction than the area of the bottom surface of a vessel for culturing cells, for example, a multiwell plate.
- the object to be processed is formed of one or more of polystyrene, polyimide, cyclic olefin-based thermoplastic resin, acrylic resin, aluminum oxide, glass, stone glass, and silicon.
- the spheroid formed on the cell culture structure is fixed on the cell culture structure having the concavo-convex structure with an uneven width of 3 jum or less. It is characterized by that.
- another structure with a spheroid of the present invention is a cell culture structure having a concavo-convex structure in which a plurality of cells having a polygonal shape in a planar direction and a minimum inner diameter of 3 jum or less are continuous. Further, the spheroid formed on the cell culture structure is fixed.
- another structure with a spheroid of the present invention is a spheroid formed from cells having a number of temporary legs per unit length of 0.1 m or more on an uneven structure. The door is fixed.
- the spheroid is cultured from cancer cells. Also
- the spheres preferably have a diameter of 1 O jum or more.
- the method for producing a structure with spheroids of the present invention includes a cell culture structure having a concavo-convex structure in which a plurality of cells having a planar shape of a polygon and a minimum inner diameter of 3 jum or less are continuously provided. Cells are seeded and cultured to form spheroids.
- the method for producing a structure with a spheroid according to the present invention includes seeding and culturing cells on a cell culture structure having a concavo-convex structure with a concavo-convex width of 3 m or less to form a spheroid. It is characterized by.
- the cell culture container of the present invention is a cell culture container for culturing cells, and has a concavo-convex structure with a concavo-convex width of 3 m or less.
- another cell culture container of the present invention is a cell culture container for culturing cells, wherein a plurality of cells having a polygonal shape in a planar direction and a minimum inner diameter of 3 m or less are continuously provided. It is characterized by having an uneven structure.
- the cell culture container of the present invention is a cell culture container for culturing cells, and has a cell culture structure having a concavo-convex structure and one or more holes. And a cylindrical member that can be coupled with the base plate as a bottom plate.
- the cell culture container of the present invention is a cell culture container for culturing cells, a cell culture structure having an uneven structure, a cylindrical member having one or more holes, and the cell culture And a bottom plate for sandwiching the structure together with the cylindrical member.
- the cell culture container of the present invention is a cell culture container for culturing cells by incorporating a cell culture structure having a concavo-convex structure, the tubular member having one or more holes, A bottom plate for sandwiching the cell culture structure together with the cylindrical member; It is characterized by providing.
- the cell culture structure preferably has an uneven structure with an uneven width of 3 m or less. Further, it is preferable that the cell culture structure has a concavo-convex structure in which a plurality of cells having a polygonal shape in the planar direction and a minimum inner diameter of 3 jum or less are continuous. Moreover, it is preferable to provide a seal member that seals between the tubular member and the cell culture structure.
- the cell preferably has a hexagonal shape in the planar direction.
- the maximum inner diameter of the cell is preferably 3 m or less.
- the width between the cells is 3 jum or less.
- the method for producing a cell culture container of the present invention is characterized in that the above-described cell culture structure of the present invention is fixed to a container for culturing cells.
- Another method for producing a cell culture container of the present invention is characterized in that an uneven structure having an uneven width of 3 jum or less is formed in a vessel for culturing cells.
- the container for culturing cells has an uneven structure in which a plurality of cells having a polygonal shape in the planar direction and a minimum inner diameter of 3 m or less are continuously provided. It is characterized by forming a cell culture structure.
- the method for producing a cell culture container of the present invention is characterized by fitting a cell culture structure having a concavo-convex structure and a cylindrical member having one or more holes.
- the method for producing a cell culture container of the present invention includes a cell culture structure having a concavo-convex structure, a cylindrical member having one or more holes, and a bottom plate disposed at the bottom of the cylindrical member; It is characterized by being inserted between and fitted.
- the cell culture structure is preferably the cell culture structure of the present invention. Moreover, it is preferable to form the concavo-convex structure using a nanoimprint technique.
- the spheroid-equipped container of the present invention is characterized in that the spheroid cultured in the cell culture container is fixed to the above-described cell culture container of the present invention.
- the method for producing a container with a spheroid of the present invention comprises the above-described cell culture of the present invention. It is characterized by seeding and culturing cells in a composition container.
- a cell culture structure and a cell culture container in which the shape, size, and material of the microstructure are controlled can be manufactured.
- a sphere suitable for drug screening evaluation can be easily and shortly made. It can be cultured at a low cost for a long time.
- FIG. 1 is an explanatory view showing an uneven structure of the present invention.
- FIG. 2 is a schematic front view showing a microfabrication apparatus of the present invention.
- FIG. 3 is a SEM photograph of a cell culture structure having a honeycomb structure of the present invention formed on a film having a film thickness of 4 Ojum.
- FIG. 4 is a SEM photograph of a cell culture structure having a honeycomb structure of the present invention formed on a film having a film thickness of 4 Ojum.
- FIG. 5 is a SEM photograph of a cell culture structure having a honeycomb structure of the present invention formed on a film having a thickness of 10 OjUm.
- FIG. 6 is a SEM photograph of a cell culture structure having a honeycomb structure of the present invention formed on a film having a thickness of 10 OjUm.
- FIG. 7 is a plan view showing a cell culture container of the present invention.
- FIG. 8 is a cross-sectional view as seen from the direction of arrows I—I in FIG.
- FIG. 9 is a cross-sectional view showing another cell culture container of the present invention.
- FIG. 10 is a cross-sectional view showing still another cell culture container of the present invention.
- FIG. 11 is a cross-sectional view showing still another cell culture container of the present invention.
- FIG. 12 Cell line U derived from human glioma cultured on the cell culture structure of the present invention
- FIG. 13 is a photograph showing a Western plotting image comparing the spheres of the present invention with monolayers of HIF-1 and P-AMPK.
- FIG. 14 is a table showing the relationship between plate efficiency and spheroid production rate of the cell culture structure of the present invention.
- FIG. 15 is an optical micrograph (magnification: 100 ⁇ ) of a spheroid formed with a human head and neck cell line SQ 2 OB cells cultured on the cell culture structure of the present invention.
- FIG. 16 is an optical micrograph (magnification: 200 ⁇ ) of spheroids formed with human colon cancer-derived cell line SW 4480 cells cultured on the cell culture structure of the present invention.
- FIG. 17 is an optical micrograph (magnification 40 times) of a spheroid formed with a human colon cancer-derived cell line HT 29 cell cultured on the cell culture structure of the present invention.
- FIG. 18 is a graph showing the relationship between the width of the unevenness of the uneven structure and the number of temporary feet.
- the cell culture structure of the present invention has an uneven structure with an uneven width of 3 ⁇ m or less.
- the width of the unevenness is, for example, 3 mm or less, 2 mm or less, 1 mm or less, 70 O nm or less, 500 nm or less, or 250 nm or less. This is preferable in that it can be grown.
- the depth of the unevenness (the vertical dimension of the workpiece 200) is 10 nm or more, 100 nm or more, 200 nm or more, 500 nm or more, 1 m or more, 10 m or more, It is formed in various sizes such as 10 Om or more.
- there are various aspect ratios of the unevenness such as 0.2 or more, 0.5 or more, 1 or more, 2 or more.
- the concavo-convex structure may be a structure in which a plurality of cells having a polygonal shape in the planar direction and a minimum inner diameter of 3 m or less are continued. This prevents the cells from growing into a single-layer cell that has spread in the two-dimensional direction (planar direction), and can be grown into a three-dimensional spheroid.
- the shape of the concavo-convex structure in the planar direction is preferably a regular polygon, and is preferably a regular triangle, square, or regular hexagon that can be formed isotropically continuously in the planar direction. This allows the spheres to grow on isotropically uniform structures.
- the minimum inner diameter of the cells (preferably the maximum inner diameter) and the width of the line 202 between the cells are
- the cell culture structure may have any shape, for example, for example, a film or a substrate (plate) can be used. Furthermore, any material may be used as long as it is non-toxic to cells. For example, “polystyrene”, “polyimide”, “cyclic olefin copolymer (
- thermoplastic resins such as cyclic olefin polymers (COP) "," acrylic resins ",” other resins such as photo-curing resins and thermosetting resins "," metals such as aluminum oxide " Materials such as “glass”, “quartz glass”, and “silicon” can be used. Further, it is also possible to use a substrate body made of silicon, glass or the like on which a coating layer such as “resin”, “photoresist”, “metal such as aluminum oxide” is formed.
- the film form means a film having a thickness of at least 1 mm or less. Also, from the viewpoint of ease of microscopic observation, it is preferable that the thickness is thin, less than 500 mm, less than 200 mm, less than 100 mm, less than 50 mm, and less than 40 mm. Various thicknesses can be used.
- the size of the cell culture structure is preferably formed to be larger than the size of the bottom surface of a normal container such as a petri dish or dish, a multi-well plate, a flask, or a chamber slide.
- a normal container such as a petri dish or dish, a multi-well plate, a flask, or a chamber slide.
- a multi-well plate it is preferable to form a plate having a length of 70 to 9 Om m and a width of 100 to 130 mm.
- the cell culture structure is in the form of a film, it is preferable that the cell culture structure is formed to be larger than the size of the bottom surface of each hole of the multi-well plate.
- 96-hole multi-wall playboard it is better to make it about 7 mm or more.
- FIG. 1 (c) the case where a groove 20 3 is formed between adjacent polygons 2 0 1 (squares) in FIG. 1 (b) is also included.
- this groove the components of the medium at the time of culturing can be spread to every corner of the cell or sphere.
- the cell culture structure manufacturing method uses nanoimprint technology that transfers the fine pattern (uneven structure) formed on the mold 100 by pressing the mold 100 against the workpiece 200 Can do.
- Nanoimprint technology includes thermal imprint There are process technology and optical imprint process technology.
- Fig. 2 shows the processing device 1 used in the thermal imprint process technology.
- the processing apparatus 1 presses the mold 100 having a predetermined pattern and the workpiece 200 to transfer the pattern of the mold to the workpiece 200
- a fine processing apparatus a mold holding unit 2 for holding a mold 100, a workpiece holding part 12 for holding a workpiece 200, and a mold 100 for the workpiece 200
- Displacement means 5 capable of adjusting the relative position of the workpiece and the displacement speed for changing the position
- position detection means 7 for detecting the relative position of the mold 1 0 0 with respect to the workpiece 2 0 0, and mold 1
- Pressure detection means 8 for detecting the pressure between 0 0 and the workpiece 2 0 0
- mold heating means 3 for heating the mold 1 0 0
- mold cooling means 4 for cooling the mold 1 0 0
- Die temperature detecting means 3 1 for detecting the temperature of 100, work object heating means 13 for heating the work object 200, and heating object cooling for cooling the work object 200
- Means 14 and workpiece temperature detection means 1 3 1 for detecting the temperature of workpiece 20 0
- the material of the mold 100 may be any material as long as the component does not adhere to the workpiece 200, for example, "metal such as nickel”, “ceramics", “glassy carbon” Carbon materials such as “Silicon”, etc. are used. Further, the mold 100 may be anything as long as it can press the workpiece 200 and can machine the workpiece 20 0, but one end surface (pattern surface 100 0 a ), A predetermined pattern of irregularities is formed. This pattern is an inversion of the uneven structure of the cell culture structure described above. This pattern can be formed by subjecting the pattern surface 100 a to precision machining.
- an electroforming method such as a nickel plating method is formed on the surface of the silicon substrate or the like. It is also possible to apply a metal plating and peel the metal plating layer to form a pattern consisting of irregularities.
- the material and manufacturing method of the mold 100 are not particularly limited as long as a fine pattern can be formed.
- the width of the unevenness of this pattern is 3 m or less, 2 jU m or less, 1 jum or less, 70 nm or less, 500 nm or less, 25 5 It is formed in various sizes such as 0 nm or less.
- the depth of the unevenness (the vertical dimension of the workpiece 200) is 10 nm or more, 100 nm or more, 2 00 ⁇ m or more, 500 nm or more, 1 mm or more. , 10 ⁇ m or more, or 100 ⁇ m or more.
- the area occupied by this pattern is preferably 900 mm 2 or more, more preferably 2500 mm 2 or more. Since this mold is heated and cooled during molding, it is preferable to make it as thin as possible and reduce its heat capacity.
- the mold holding unit 2 is fixed to the mold holding surface 2a holding the mold 100 so that the mold 100 is in surface contact with a fastener such as a screw clamp fitting. It is formed as possible.
- the structure of the mold holding part 2 may be any structure as long as the mold 100 is held on the mold holding surface 2a. For example, electrostatic chucking or vacuum suction is applied to the mold holding surface 2a. It is also possible to adopt a structure for holding by adsorption.
- the mold holding unit 2 includes a mold heating means 3 for heating the mold 100, for example, a carbon heater having very good responsiveness.
- the carbon heater is controlled to supply current from a power source (not shown) by the control means 300, and can maintain the mold 100 at a predetermined constant temperature.
- a heat transfer heater for example, a ceramic heater, a halogen heater, an IH heater, or the like can be used.
- the mold holding unit 2 is provided with a mold cooling means 4 for cooling the mold 100.
- a mold cooling means 4 for example, a cooling liquid such as water or oil, or a cooling gas such as air or inert gas is allowed to flow inside the mold holding part 2 formed of a metal having high thermal conductivity such as aluminum or copper.
- a cooling channel that can cool the mold 100 Can.
- the mold holding unit 2 is provided with mold temperature detection means 31 for detecting the temperature of the mold 100, for example, a thermocouple.
- the mold temperature detection means 3 1 is electrically connected to the control means 3 0 0 and is formed so as to transmit the detected information relating to the temperature of the mold 1 0 0 to the control means 3 0 0. .
- the workpiece holding unit 12 holds the workpiece 200 in a substantially horizontal state, and has a workpiece holding surface 12 a on the upper surface. It has a swage.
- a large number of vacuum holes are formed in the workpiece holding surface 12 a, and negative pressure is applied to the vacuum holes from a negative pressure source (not shown).
- the workpiece 2 is held on the workpiece holding surface 1 2 a by suction.
- the structure of the workpiece holding part 1 2 may be any structure as long as it holds the workpiece 2 0 0 on the workpiece holding surface 1 2 a.
- a fastener such as a clamp fitting It is of course possible to adopt a structure in which the workpiece is held on the workpiece holding surface 1 2 a or is held by adsorption by electrostatic adsorption.
- a workpiece heating means 13 for heating the workpiece 20 that is held is provided below the holding stage, for example, a highly responsive carbon heater.
- the carbon heater is controlled to supply current from a power source (not shown) by the control means 300, and can maintain the workpiece 200 on the holding stage at a predetermined constant temperature.
- a heat transfer heater, a ceramic heater, a halogen heater, an IH heater, or the like can be used.
- the workpiece holding section 12 can be provided with a workpiece cooling means 14 for cooling the workpiece 200.
- the workpiece cooling means 14 includes, for example, a coolant such as water or oil, air, inert gas, etc. inside the workpiece holding part 12 formed of a metal having high thermal conductivity such as aluminum or copper. It is necessary to use a cooling flow path that can cool the workpiece 200 by flowing a cooling gas of You can.
- the workpiece holding unit 12 is provided with a workpiece temperature detection means 13 1, for example, a thermocouple, for detecting the temperature of the workpiece 200.
- the processing object temperature detection means 1 31 is electrically connected to the control means 3 0 0 so that the detected information on the temperature of the processing object 2 0 0 is transmitted to the control means 3 0 0. Is formed.
- the displacing means 5 is composed of, for example, a ball screw 51 arranged in the vertical direction and an electric motor 52 that drives the ball screw 51 to rotate. Further, the lower end portion of the ball screw 51 and the upper surface of the mold holding portion 2 are connected via a pressing portion 53 and a bearing mechanism 54. Then, by rotating the ball screw 51 with the electric motor 52, the pressing portion 53 is formed on a plurality of, for example, four struts 56 provided between the base 50 and the upper base 55. It can be displaced in the contact / separation direction of the workpiece 100 and the workpiece 200 (hereinafter referred to as the Z direction).
- the displacement means 5 is capable of adjusting the position of the mold 100 relative to the workpiece 200 with a displacement amount not more than the depth of the pattern of the mold 100.
- the amount of displacement can be adjusted to 100 m or less, preferably 10 U m or less, more preferably 1 m or less, more preferably 100 nm or less, and further.
- one that can be adjusted to 1 O nm or less, more preferably 1 nm or less is preferable.
- the displacement means 5 is preferably capable of adjusting the displacement speed of the mold 100 with respect to the workpiece 200. Specifically, it can be adjusted within 10 O jU mZ seconds or less, preferably 10 seconds or less, more preferably 1 second or less, more preferably 1 00 n seconds or less, and even more preferably 1 On. It should be adjustable in seconds or less, more preferably 1 n mZ seconds or less. This is because the control means 3 0 0 controls the operation of the displacement means 5 based on the information detected by the pressure detection means 8 and adjusts the pressure between the mold 1 0 0 and the workpiece 2 0 0. Pressure detection It takes some time for the information detected by the output means 8 to be fed back to the displacement means 5. Therefore, if the displacement speed is too high, the information detected by the pressure detection means 8 is delayed in feeding back to the displacement means 5, and the actual pressure between the mold 100 and the workpiece 2 0 0 is accurately controlled. Because you wo n’t be able to
- the displacement means 5 is composed of a ball screw and an electric motor as long as the relative displacement amount and displacement speed between the mold 100 and the workpiece 200 can be adjusted.
- a piezoelectric element that can change the size (dimension) by adjusting the voltage or a magnetostrictor that can change the magnitude (dimension) by adjusting the magnetic field can be used.
- a pole screw and an electric motor are applied to greatly displace the mold 100 and the workpiece 200, and a small amount of displacement between the mold 100 and the workpiece 200 is applied.
- a piezoelectric element or a magnetostrictive element can be used.
- the mold holder 2 that holds the mold 100 is moved up and down, so that the workpiece 5 held by the workpiece holding part 12 is opposed to the workpiece 200.
- the pattern surface 100 a of the mold 100 a can be closely approached and pressed and separated.
- the position detection means 7 is formed by, for example, a linear scale arranged in the mold holding unit 2. Using this linear scale, the distance between the workpiece 2 0 0 and the mold holder 2 is measured, and the relative position and displacement speed of the mold 1 0 0 with respect to the workpiece 2 0 0 are calculated from the measured values. Can be detected.
- the position detection means 7 is electrically connected to the control means 300, and is configured to transmit information on the detected position and displacement speed of the mold 100.
- the position detection means 7 is not limited to a linear scale, and various types can be used. For example, the position of the workpiece 200 is measured using a laser length measuring device provided on the mold holding unit 2 side, or a laser length measuring device provided on the processing object holding unit 12 side is used.
- the position of the mold 100 may be measured. Further, it may be measured by calculation from the displacement amount of the displacement means 5 using an encoder provided in the electric motor.
- the resolution of the position detection means 7 can be detected with a value that is at least smaller than the size of the pattern 100 in the depth direction (Z direction) or less than the amount of displacement that the displacement means 5 can adjust. Is preferred. Specifically, those that can be detected at 1 OO jU m or less are good, preferably 1 O jU m or less, more preferably 1 m or less, more preferably 100 nm or less, more preferably 1 O nm or less, more preferably 1 nm or less can be detected
- the mold for the workpiece 2 0 0 can be selected according to the size of the pattern and the pressure between the mold 1 0 0 and the workpiece 2 0 0. Since the position of the 100 0 pattern surface 1 0 0 a can be precisely adjusted, the pattern transferability and releasability can be improved.
- the pressure detection means 8 detects the pressure between the mold 100 and the workpiece 200, for example, the load between the mold 100 and the workpiece 200 A load cell to be measured can be used. As a result, if the load is measured and divided by the area of the pattern surface 100 a of the mold 100 a, the pressure between the mold 100 and the workpiece 200 can be detected. Further, the pressure detection means 8 is electrically connected to the control means 300 and is configured to transmit information regarding the detected pressure.
- the control means 3 0 0 includes a position detection means 7, a pressure detection means 8, a mold temperature detection means 3
- the displacement speed to be adjusted depends on the material and temperature of the workpiece 200. For example, it is better to adjust it at 100 seconds or less, preferably 10 milliseconds or less, more preferably 1 UL seconds or less, more preferably 10 00 n seconds or less, more preferably 1 On seconds or less, More preferably, it should be adjusted within 1 ns.
- the actual pressure between the mold 100 and the workpiece 200 can be reliably adjusted to a predetermined value or less.
- at least one of the mold heating means 3 and the workpiece heating means 1 3 is controlled to change the temperature of the molding surface 2 00 a of the workpiece 2 0 0 a. It is also possible to adjust the pressure between the mold 100 and the workpiece 200.
- a method for producing a cell culture structure using the processing apparatus 1 is as follows.
- the mold 100 and the workpiece 200 are heated to a predetermined temperature for molding.
- the mold 100 is preferably heated to a temperature higher than the workpiece 200, more preferably, the mold. 1 0 0 is heated to a temperature higher than the softening temperature (glass transition point and melting point) at which the workpiece 2 0 0 softens, and the workpiece 2 0 0 is heated to its softening temperature (glass transition point and melting point). It is preferable to heat to a lower temperature.
- the heating temperature depends on the material of the workpiece 200 and the material of the mold 100. For example, the softening temperature (Tg) + 20 at which the workpiece is softened. C or higher, softening temperature (T g) + 2 5. C or higher, softening temperature (T g) +
- the mold 1 0 0 and the workpiece 2 0 0 are pressed with a preset pressure.
- the pressure between the object 200 and the object 200 should be as small as possible as long as the pattern of the mold 100 can be transferred to the object 200.
- 4 MPa or less preferably 2 MPa or less, more preferably 1.5 MPa or less, more preferably 1 MPa or less, more preferably 0.5 MPa or less, more preferably 0.25 MP. It should be less than a.
- the pressure is pressed with a relatively lower pressure than before, so that the adhesion between the mold 100 and the workpiece 200 is not increased, and the mold can be easily released by preventing the collapse of the mold. Can do.
- the displacement speed of the mold 100 relative to the workpiece 200 can be adjusted so that the pressure between the mold 100 and the workpiece 200 does not always exceed a preset pressure, for example, 4 MPa. Better to speed. More preferably, it is preferable to control and press the displacement amount of the mold 100 with respect to the workpiece 200.
- the atmosphere of the mold 100 and the workpiece 200 is evacuated. Is preferred. In this case, it is only necessary to create a vacuum atmosphere before pattern transfer. Considering oxidation of the workpiece 200 or the like, it is preferable to create a vacuum atmosphere before heating the workpiece 200.
- the degree of vacuum may be 40 Pa or less, for example.
- the mold 100 and the workpiece 200 are cooled, and the temperature of the workpiece 200 is reduced to a glass transition temperature (or softening temperature) or lower.
- the cooling temperature may be a softening temperature (T g) _5 ° C or lower, a softening temperature (T g) _45 ° C or lower, and a softening temperature (T g) _90 ° C or lower.
- T g softening temperature
- T g softening temperature
- the mold 100 and the workpiece 200 are released, and the process of the fine processing method is completed.
- the object of the transferred pattern is formed, it is preferably greater, for example, 9 OOmm 2 or more, more preferably it is 25 300 mm 2 or more in size .
- the concavo-convex structure may be formed on the surface by other methods such as blasting, corona discharge, and etching. Also good.
- the cell culture structure is preferably formed to have an uneven width of 3 jum or less, and preferably 2 jum or less, 1 ⁇ m or less, 700 nm or less, 500 nm or less, or 250 nm or less.
- the size of the cell culture structure is larger than the size of the bottom of a normal container such as a dish or dish, a multiwell plate, a flask, or a chamber slide.
- a normal container such as a dish or dish, a multiwell plate, a flask, or a chamber slide.
- the cell culture structure is in the form of a sheet or film, it is preferable that the cell culture structure is formed to be larger than the size of the bottom surface of each hole of the multiwell plate.
- a 96-hole multi-wall plate it is better to make it about 7 mm or more.
- the cell culture vessel 210 of the present invention is a vessel for culturing cells, and has an uneven structure with an uneven width of 3 m or less formed in the container.
- Any container can be used as long as it can cultivate cells. Examples thereof include a petri dish or dish for culturing, a multiwell plate, a flask, and a titanium slide.
- the uneven structure may be formed by, for example, fixing the above-described cell culture structure of the present invention to at least a part of the container.
- the cell culture container is a petri dish or a multi-wall plate, for example, as shown in FIGS. 7 and 8, a cylindrical member 2 1 2 having one or more holes 2 11 1; A plate-shaped cell culture structure 2 20 described above, or a cylindrical member 2 1 2 having one or more holes 2 1 1 and a sheet as shown in FIG.
- the above-described cell culture structure 2 20 in the form of a film and the substrate 2 1 3 that sandwiches and integrates the cell culture structure 2 2 0 between the cylindrical members 2 1 2 may be configured. .
- Non-toxic adhesives include, for example, Fallon Alpha (trade name) and the like, and at least the cylindrical member 2 1 2 and the cell culture structure 2 20 may be joined so as to be sealed.
- At least the cylindrical member 2 1 2 or the cell culture structure 2 2 0 is heated and joined to near the glass transition temperature or the melting point.
- ultrasonic vibration energy is converted into frictional heat, and at least one of the cylindrical member 2 1 2 and the cell culture structure 2 2 0 is bonded to the glass transition temperature or the melting point by using ultrasonic welding. It ’s fine.
- a pattern on which a predetermined pattern is formed is pressed into a normal petri dish or multi-well plate container, and the same pattern as the above-described cell culture structure is transferred to the bottom surface of the container. You may do it.
- a mold is used that is slightly smaller than the size of the hole 2 11 in the container, and the pattern is formed by inserting the mold into the hole while moving over the hole in the container.
- a plurality of the stamp-shaped molds may be arranged and inserted into a plurality of holes to form a pattern in a lump.
- a seal member 2 15 that seals between the cylindrical member 2 12 and the cell culture structure 2 2 for example, It is preferable to dispose a gasket made of silicon rubber or the like.
- This gasket is a cylinder Of course, it may be formed integrally by applying silicon rubber or the like to the shaped member 21 2 or the cell culture structure 2 20.
- the cells used here are mesenchymal cells, hepatocytes, fibroblasts, endothelial cells, neurons, cardiomyocytes, glia cells, corneal epithelial cells, chondrocytes, osteoblasts, adipocytes, etc.
- Normal cells cancer cell lines (eg, HepG2, HuH-7), immortalized cells (eg, HHY41, NKNT-3, Fa2N-4 strains), and chromosomal abnormalities
- Abnormal cells such as cells can be used.
- a medium used for the culture can be appropriately prepared and used by those skilled in the art according to the type of the target cell.
- the cell culture structure and the cell culture container of the present invention both have a structure in which cells adhere to the surface thereof, so that the spheres produced by the culture are formed on the structure or container. .
- the reason for this is considered to be that a large number of temporary limbs grow on the cell culture structure of the present invention to make a firm scaffold on the uneven structure.
- a temporary foot of 0.1 m or more per unit length of the circumference is formed around the cell. Therefore, medium change during culturing for spheroid formation can be performed in the same manner as normal culture, and spheroids can be easily formed while changing medium.
- the size of the spheroidal may be 1 O jum or more, preferably
- 15 to 50 m is better, more preferably 20 to 40 m, and even more preferably 25 to 35 jum, but depending on the purpose of using the sphere, Larger spheres can be formed by repeated exchange and incubation. Noh.
- the “size of spheroid” in the present invention refers to the major axis on a plane parallel to the cell culture structure or cell culture container, and can be accurately measured by observation with an optical microscope or observation with an electron microscope. .
- the sphere obtained by such a method is mainly composed of clonal cells generated by the division of a single cell.
- cancer cells that can be formed in a living body are not formed by aggregation of a plurality of cells as in the prior art sphere (the sphere described in Patent Document 1), but are formed by dividing a single cell. Therefore, in the present invention, it is possible to culture a sphere having properties closer to cancer cells that can be formed in a living body, and to perform screening with higher accuracy.
- such a sphere has properties common to various tissues existing in the living body, and reproduces the tissue environment in the living body more than the monolayer culture.
- the spheres obtained by the present invention are cultured on fine structures artificially controlled by various materials, so that the adhesion area to the solid phase on which the fine structures are formed is controlled.
- the That is, the fixing area can be adjusted to less than 50%, preferably less than 40%, and more preferably less than 30% of the total surface area of the sphere.
- the spheroid fixed to the solid phase in this way is a conventional non-fixed spheroid (a spheroid formed by flowing a medium in a spheroid flask formed in an agarose gel).
- a cell adhesion factor, cell adhesion protein or cytoskeletal protein for the extracellular matrix is strongly expressed.
- cell adhesion factor, cell adhesion protein, and cytoskeleton protein include integrins, cadherins, and actin. These are all known to be closely related to cell adhesion.
- actin can be measured by the following method.
- the cultured cells that form the spheroids are fixed, treated with a surfactant or the like, lysed, and further blocked with BSA (Bovine serum albumin) or the like.
- BSA Bovine serum albumin
- An anti-actin antibody or the like is bound to the sample thus prepared, and a secondary antibody or the like labeled with a labeling substance such as a fluorescent substance is bound to the bound antibody to detect the labeling substance or the like.
- Actin can be measured by quantification.
- the spheroid obtained by the present invention realizes an environment similar to that of tumors and tissues such as lack of oxygen and lack of nutrition.
- high expression of proteins expressed in the state of lack of oxygen for example, HIF-1 protein, etc.
- Phenomena observed in the state of lack of nutrition for example, increased phosphorylation of AMPK, etc .
- phosphorylation of AMPK is enhanced, it is 1.5 times or more, preferably 2 times or more that in monolayer culture, more preferably Can be confirmed by the confirmation of an increase of more than 2.5 times.
- Those skilled in the art can appropriately observe these by Western plotting using specific binding pairs (antibodies, receptors, etc.) and immunostaining.
- the spheroids obtained by the present invention thus produced can be used for drug screening.
- chemical substances, drugs, etc. can be added to the spheroids fixed to the cell culture substrate or cell culture vessel, and those having some effect on the cells forming the spheroids can be screened. .
- the sphere of the present invention can also be used for differentiation of disease malignancy. That is, tissue fragments collected from a living body are dispersed into cells. Then, in the course of making the sphere of the present invention, the proliferative ability can be evaluated, or the presence or absence of free cells from the sphere can be evaluated to evaluate the cancer metastasis ability.
- the sphere of the present invention can also be used for regenerative medicine. That is, by preparing the sphere of the present invention from cells collected from healthy tissue and injecting the sphere directly or indirectly into the relevant tissue of patients or animals requiring treatment, the function of the relevant tissue can be maintained. ⁇ Can be used for playback.
- the sphere of the present invention can also be used for food function evaluation.
- functional foods, active ingredients in foods, etc. are added to the spheroids adhering to the cell culture substrate or cell culture container to screen for those that have some effect on the cells that form the spheroids. can do.
- the sphere of the present invention can also be used for safety evaluation of foods or drugs.
- foods, drugs, etc. are added to the spheroids adhering to the cell culture substrate or cell culture container, and the morphological and biochemical changes of the cells forming the spheroids are verified. It is possible to evaluate the safety of substances.
- transparent films with a glass transition temperature ⁇ softening temperature (T g) ⁇ of 13.6 ° C and a film thickness of 40 m and 10 0 m are made of cycloolefin polymer ( Zeon Corporation ZF 1 4) was used.
- a micro molding apparatus (VX-2000N-US) manufactured by SCI VAX was used for evaluation of micro molding.
- the mold has a pattern that can transfer the concavo-convex structure consisting of line and space when transferred to the workpiece, and a pattern that can transfer a regular hexagonal honeycomb structure (a pattern in which the honeycomb structure is reversed) Also have Two of these were used. Further, this mold was made of nickel, and a transferable area force ⁇ 5 Omm X 5 Omm (the outer shape of the mold was 55 mm X 55 mm): a square having an area of 2500 mm 2 was used.
- the concavo-convex structure consisting of line and space has a concavo-convex depth of 1 mm and a concavo-convex width of 10 mm, 5 mm, 4 mm, 3 U 2 mm, 1 U 700 nm, 500 Eight types of nm regions were formed.
- the honeycomb structure has a line width of 250 nm, a height of 380 nm (aspect ratio of about 1.5), and a maximum inner diameter of one cell (hexagon) of 2 jum (ie, line width). The maximum outer diameter including that is 2.5 ⁇ ).
- the film with a film thickness of 40 m was cooled to the glass transition temperature deficiency temperature (T g) ⁇ -46 ° C (90 ° C) while keeping the mold pressure constant. After completion of cooling, the mold was released from the film at a speed of 1 O mZ seconds.
- SEM scanning electron microscope
- a pattern of uniform and good concavo-convex structure (line and space and honeycomb structure) without stretching or peeling was transferred over the entire transfer area.
- Fig. 3 shows a planar photograph (magnification: 10,000 times) after transfer of a pattern composed of a honeycomb structure
- Fig. 4 shows a photograph from the perspective (magnification: 5,000 times).
- a film having unevenness can be produced by roughening the surface of a 3 mm-thick polystyrene plate by conventional blasting.
- a polystyrene film having a film thickness of 4 Om can be roughened by a conventional corona discharge to produce a film with irregularities.
- the cell culture structure (honeycomb structure) having a thickness of 4 Ojum manufactured in Example 1 was cut to a size of 1.5 cm square, and this was heat-sealed in a petri dish having a diameter of 3.5 cm.
- the cell culture container of the present invention was prepared by fixing.
- one MEM medium (10% fetal bovine serum, 20 mmo I / IH EP ES, 8 mmo I / I sodium bicarbonate, 42000 units I penicillin, and A cell line U 251 cell derived from human glioma was seeded together with 2m I together with 0.03 I streptomycin.
- This 37 ° C, 2% C0 2 in the atmosphere for 7 days (middle, the medium was replaced on day 6 eyes 3 days) is Sufuweroi de were cultured formed (see FIG. 1 2), the present invention A spheroided structure was formed.
- HIF-1 protein using anti-HI F-1 Usagi polyclonal antibody: Santa Cruz Biotech Co., Ltd.
- Phosphorylation of AMP K anti-AMP K Usagi polyclonal antibody: manufactured by Cell Signaling Technology Co., Ltd.
- U 251 cells were used which were seeded at a similar cell density in a conventional polystyrene culture dish and cultured after changing the medium.
- the results are shown in Figure 13.
- the Western plot method was performed by the following method. First, 20 g of total protein extracted from cultured cells was electrophoresed on a pregel gel (ATT0 polyacrylamide gel G pager).
- the cells were transferred to a PVDF membrane (ATTO clear blot ⁇ P membrane) with a blotting buffer (20 mM GI cyne / 25 mM TrisHC I / 20% Methano I, pH 8.0).
- the PVDF membrane after transfer is blocked with 5% BSA TBST (20 mM Tris-HCI / 0.15 M NaCI / 0.1% Tween (trade name) 20, pH 8.0) solution, and then 1% BSA containing the primary antibody.
- BSA TBST 20 mM Tris-HCI / 0.15 M NaCI / 0.1% Tween (trade name) 20, pH 8.0) solution, and then 1% BSA containing the primary antibody.
- incubation was performed in a solution containing a secondary antibody for 1 hour.
- detection was performed by chemiluminescence (GL / Amersham ECLplus).
- the cultured spheroids have higher expression levels of HIF-1 protein than monolayer cells, and AMP K phosphorylation is more enhanced than monolayer cells. It can be seen that it exhibits properties that are closer to tissues in the body than monolayer cells. This indicates that the spheroids obtained by the present invention are useful for tests such as drug resistance and toxicity.
- actin filaments were measured for the spheroids thus formed.
- the actin filament was measured by the following method. First, the cultured cells are washed twice with PBS. Fix with 3% Folmaldehyde / PBS for 15 minutes and wash twice with PBS. Next, treat with 0.1% " ⁇ 0 ⁇ -100 /? 85 for 15 minutes and wash twice with BS. Then block with 1% BSA / PBS for 30 minutes and wash twice with PBS.
- the plate efficiency is calculated as the ratio (%) of the number of colonies per unit area at the start of 3 days of cultivation to the number of cells seeded per unit area.
- the spheroid production rate is the unit area The ratio of the number of spheroids formed per unit area when the culture started 7 days to the number of cells seeded per unit (%) And calculated.
- Example 4 In the cell culture container of the present invention prepared in Example 4, one MEM medium (10% fetal bovine serum, 2 Ommo II HEPES, 8 mmo II sodium bicarbonate, 42000 units I penicillin, and 0.03 I streptomycin 100 ml of a human head and neck cell line SQ 20 B cell was seeded together with 2 m I. This 37 ° C, 2% C0 2 in the atmosphere for 7 days Sufueroi de was (middle went medium change on day 3 and day 6) culture is formed (see FIG. 1 5), the present invention A structure with spheroids was formed.
- MEM medium % fetal bovine serum, 2 Ommo II HEPES, 8 mmo II sodium bicarbonate, 42000 units I penicillin, and 0.03 I streptomycin 100 ml of a human head and neck cell line SQ 20 B cell was seeded together with 2 m I. This 37 ° C, 2% C0 2 in the atmosphere for 7 days Sufueroi de was
- Example 4 In the cell culture container of the present invention prepared in Example 4, one MEM medium (10% fetal bovine serum, 2 Ommo II HEPES, 8 mmo II sodium bicarbonate, 42000 units I penicillin, and 0.03 I Streptomycin 100 ml of human colon cancer cell line SW480 cells were seeded together with 2m I. This 37 ° C, 2% C0 under 2 atmosphere for 7 days (middle, medium exchange was performed on day 3 and day 6) Sufuweroi de were cultured is formed (see FIG. 1 6), the present invention A structure with spheroids was formed.
- MEM medium 10% fetal bovine serum, 2 Ommo II HEPES, 8 mmo II sodium bicarbonate, 42000 units I penicillin, and 0.03 I Streptomycin 100 ml of human colon cancer cell line SW480 cells were seeded together with 2m I. This 37 ° C, 2% C0 under 2 atmosphere for 7 days (middle, medium exchange was performed on day 3 and day 6) Suf
- the MEM medium (10% fetal bovine serum, 20 mmo I / IH EP ES, 8 mmo I / I sodium bicarbonate, 42000 units I penicillin in the cell culture container of the present invention prepared in Example 4 , And 0.03 I containing streptomycin) 1 000 29 human colon cancer-derived HT 29 cells were seeded together with 2m I. This 37 ° C, 2% C0 2 in the atmosphere for 7 days Sufuweroi de was (middle went medium change on day 3 and day 6) culture is formed (see FIG. 1 7), the present invention A structure with spheroids was formed.
- a cell culture structure having a thickness of 40 m manufactured in Example 1 (Line and Space) The cell culture vessel of the present invention was prepared by cutting the sample into a 1.5 cm square and fixing it in a sheath having a diameter of 3.5 cm by heat fusion.
- one MEM medium (10% fetal calf serum, 2 Ommo II HEPES, 8 mmo II sodium bicarbonate, 42000 units I penicillin, and 0.03 I Streptomycin 1 000 normal liver cell lines were seeded with 2m I. This 37 ° C, 2% C0 Sufueroi de with pseudopodia were cultured for 8 hours under 2 atmosphere is formed in the cell culture structure.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/280,125 US7727759B2 (en) | 2006-02-21 | 2007-02-21 | Structure for cell culture, cell culture vessel, structure with spheroid, vessel with spheroid, and manufacturing methods thereof |
KR1020087022920A KR101362293B1 (ko) | 2006-02-21 | 2007-02-21 | 세포배양구조체, 세포배양용기, 스페로이드를 갖는 구조체,스페로이드를 갖는 용기 및 이들의 제조방법 |
JP2008501635A JP4159103B2 (ja) | 2006-02-21 | 2007-02-21 | 細胞培養構造体、細胞培養容器、スフェロイド付き構造体、スフェロイド付き容器およびこれらの製造方法 |
EP07713488.0A EP1988152B1 (en) | 2006-02-21 | 2007-02-21 | Cell culture construct, cell culture container, construct having spheroid, container having spheroid and method of producing the same |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006043225 | 2006-02-21 | ||
JP2006043224 | 2006-02-21 | ||
JP2006-043225 | 2006-02-21 | ||
JP2006-043224 | 2006-02-21 | ||
JP2006340947 | 2006-12-19 | ||
JP2006-340947 | 2006-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007097120A1 true WO2007097120A1 (ja) | 2007-08-30 |
Family
ID=38437167
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/000107 WO2007097121A1 (ja) | 2006-02-21 | 2007-02-21 | スフェロイドおよびスフェロイド群並びにこれらの製造方法 |
PCT/JP2007/000106 WO2007097120A1 (ja) | 2006-02-21 | 2007-02-21 | 細胞培養構造体、細胞培養容器、スフェロイド付き構造体、スフェロイド付き容器およびこれらの製造方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/000107 WO2007097121A1 (ja) | 2006-02-21 | 2007-02-21 | スフェロイドおよびスフェロイド群並びにこれらの製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7727759B2 (ja) |
EP (1) | EP1988152B1 (ja) |
JP (2) | JP5397934B2 (ja) |
KR (1) | KR101362293B1 (ja) |
WO (2) | WO2007097121A1 (ja) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010017128A (ja) * | 2008-07-10 | 2010-01-28 | Toyota Central R&D Labs Inc | 培養細胞のハンドリング体、その製造方法及びその利用 |
JP2010022366A (ja) * | 2008-06-16 | 2010-02-04 | Scivax Kk | スフェロイド作製方法 |
JP2011019413A (ja) * | 2009-07-14 | 2011-02-03 | Scivax Kk | 細胞剥離抑制器具及びこれを用いた培養容器、細胞剥離抑制方法 |
JP2011050295A (ja) * | 2009-09-01 | 2011-03-17 | Scivax Kk | 細胞培養構造体、細胞培養容器及びこれらの製造方法 |
WO2013069490A1 (ja) * | 2011-11-08 | 2013-05-16 | 大日本印刷株式会社 | 細胞培養容器の製造方法 |
JP2013099287A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | ボトル型の細胞培養容器及びその製造方法 |
JP2013099279A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 樹脂製細胞培養容器とその製造方法 |
JP2013099275A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 機能性フィルムを移送するための負圧吸着ヘッドとそれを用いた機能性フィルムの移送方法 |
JP2013099285A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 細胞培養容器の製造方法 |
JP2013102737A (ja) * | 2011-11-15 | 2013-05-30 | Covalent Materials Corp | 細胞培養担体及びその製造方法 |
JP2013106529A (ja) * | 2011-11-17 | 2013-06-06 | Dainippon Printing Co Ltd | 機能性フィルムの移送装置 |
JP2015008701A (ja) * | 2013-07-01 | 2015-01-19 | 独立行政法人理化学研究所 | 分化転換制御方法および基板 |
JP2017181722A (ja) * | 2016-03-30 | 2017-10-05 | Jsr株式会社 | ラインパターン、光制御部材および光学結像部材の製造方法 |
US9790465B2 (en) | 2013-04-30 | 2017-10-17 | Corning Incorporated | Spheroid cell culture well article and methods thereof |
JP2018512930A (ja) * | 2015-03-26 | 2018-05-24 | フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー.ファオ. | 人工デスメ膜 |
JP2018085978A (ja) * | 2016-11-30 | 2018-06-07 | 旭硝子株式会社 | 培養容器 |
WO2020166279A1 (ja) * | 2019-02-14 | 2020-08-20 | 王子ホールディングス株式会社 | 細胞シート形成部材、基材、および、細胞シート形成部材の製造方法 |
US11345880B2 (en) | 2017-07-14 | 2022-05-31 | Corning Incorporated | 3D cell culture vessels for manual or automatic media exchange |
US11584906B2 (en) | 2017-07-14 | 2023-02-21 | Corning Incorporated | Cell culture vessel for 3D culture and methods of culturing 3D cells |
US11603515B2 (en) | 2017-03-31 | 2023-03-14 | National University Corporation Hokkaido University | Cell culture substrate, cancer cell aggregate and method for manufacturing same using said substrate, and drug screening method using said cancer cell aggregate |
US11613722B2 (en) | 2014-10-29 | 2023-03-28 | Corning Incorporated | Perfusion bioreactor platform |
US11661574B2 (en) | 2018-07-13 | 2023-05-30 | Corning Incorporated | Fluidic devices including microplates with interconnected wells |
US11732227B2 (en) | 2018-07-13 | 2023-08-22 | Corning Incorporated | Cell culture vessels with stabilizer devices |
US11767499B2 (en) | 2017-07-14 | 2023-09-26 | Corning Incorporated | Cell culture vessel |
US11857970B2 (en) | 2017-07-14 | 2024-01-02 | Corning Incorporated | Cell culture vessel |
US11912968B2 (en) | 2018-07-13 | 2024-02-27 | Corning Incorporated | Microcavity dishes with sidewall including liquid medium delivery surface |
US11976263B2 (en) | 2014-10-29 | 2024-05-07 | Corning Incorporated | Cell culture insert |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100946643B1 (ko) * | 2007-11-30 | 2010-03-09 | 코아스템(주) | 세포배양장치 및 이를 구비한 대용량 자동화 세포배양기 |
JP4578517B2 (ja) * | 2007-12-26 | 2010-11-10 | Scivax株式会社 | インプリント装置およびインプリント方法 |
KR101001296B1 (ko) * | 2008-11-04 | 2010-12-14 | 한국전자통신연구원 | 3차원 신경회로망 구현장치 |
US20110189761A1 (en) * | 2009-01-26 | 2011-08-04 | Island Giant Development Llp | Method for producing cell culture scaffold |
JP2010188426A (ja) * | 2009-01-26 | 2010-09-02 | Emprie Technology Development LLC | 清拭シート |
JP4815496B2 (ja) | 2009-01-26 | 2011-11-16 | エンパイア テクノロジー ディベロップメント エルエルシー | ナノポーラス表面を有する立体製品の製造方法 |
GB0903040D0 (en) * | 2009-02-23 | 2009-04-08 | Univ Glasgow | Retention of a stem cell phenotype |
JP4483994B1 (ja) * | 2009-02-26 | 2010-06-16 | 株式会社豊田中央研究所 | 細胞培養担体及びその利用 |
JPWO2011052281A1 (ja) * | 2009-10-30 | 2013-03-14 | 国立大学法人 東京大学 | 神経スフェロイドネットワークの構築方法 |
WO2011077894A1 (ja) * | 2009-12-25 | 2011-06-30 | Scivax株式会社 | スフェロイド形成促進方法およびスフェロイド形成促進培地 |
JP5767481B2 (ja) * | 2010-02-15 | 2015-08-19 | 丸善石油化学株式会社 | 機能性容器成形方法、成形用金型およびこれらを用いて製造した機能性容器 |
EP3443991A1 (en) * | 2010-05-25 | 2019-02-20 | Cook Biotech Incorporated | Methods, substrates, and systems useful for cell seeding of medical grafts |
WO2013042360A1 (ja) * | 2011-09-20 | 2013-03-28 | 株式会社クラレ | 接着性細胞の培養方法 |
CN104903726A (zh) * | 2012-09-05 | 2015-09-09 | Jsr株式会社 | 对细胞的上皮性维持起作用的物质的筛选方法 |
KR102234887B1 (ko) * | 2013-04-19 | 2021-04-01 | 주식회사 에이엔케이 | 세포배양 기판 |
WO2015163043A1 (ja) | 2014-04-22 | 2015-10-29 | 株式会社日本触媒 | フッ素含有ポリマーを表面に含む細胞培養用基材 |
JP6420838B2 (ja) | 2014-08-13 | 2018-11-07 | 三井化学株式会社 | 医療器具、細胞培養方法、フッ素含有環状オレフィンポリマーおよびフッ素含有環状オレフィンポリマー組成物 |
KR101647793B1 (ko) * | 2014-09-02 | 2016-08-12 | 충남대학교산학협력단 | 온도 감응성 글리콜 키토산 유도체를 이용한 스페로이드 형성용 배양 용기 및 이를 이용한 스페로이드 형성 방법 |
WO2016158039A1 (ja) | 2015-03-31 | 2016-10-06 | 三井化学株式会社 | 医療器具、フッ素含有環状オレフィンポリマー、フッ素含有環状オレフィンポリマー組成物、および細胞培養方法 |
KR101743231B1 (ko) | 2015-09-18 | 2017-06-02 | 한국생명공학연구원 | 세포 스페로이드 배양기를 포함하는 세포 스페로이드 배양 시스템 |
WO2017059227A1 (en) * | 2015-09-30 | 2017-04-06 | University Of Houston System | Multi-use combined micro and nanowell plates |
TW201730330A (zh) * | 2016-01-20 | 2017-09-01 | Soken Chemical & Engineering Co Ltd | 細胞培養基板及其製造方法 |
EP4349972A3 (en) | 2016-02-22 | 2024-05-29 | Osaka University | Method for producing three-dimensional cell tissue |
JP6792777B2 (ja) | 2016-02-22 | 2020-12-02 | 凸版印刷株式会社 | スフェロイド形成促進方法 |
KR101800249B1 (ko) * | 2016-12-23 | 2017-12-20 | 주식회사 티앤알바이오팹 | 세포 프린팅 조성물의 혼합 장치 |
JP6995476B2 (ja) * | 2016-12-28 | 2022-01-14 | デクセリアルズ株式会社 | 培養容器カバー、培養容器カバーの製造方法、及びカバー付き培養容器 |
KR101935989B1 (ko) | 2017-01-18 | 2019-01-07 | 서강대학교산학협력단 | 하이드로젤 마이크로웰을 이용한 멀티셀룰라 스페로이드의 제조 방법 |
KR102038068B1 (ko) * | 2017-06-28 | 2019-10-29 | 충남대학교산학협력단 | 세포배양용 용기의 제조방법 및 이를 이용한 세포배양 방법 |
KR101965900B1 (ko) * | 2017-11-03 | 2019-04-05 | 한국화학연구원 | 스페로이드 형성 및 카운팅 기기 및 이의 제조 방법, 그리고 이를 이용한 스페로이드 배양 방법 및 계수 방법 |
JP6854500B2 (ja) * | 2018-09-21 | 2021-04-07 | シャープ株式会社 | 三次元培養法、三次元培養構造体、および三次元培養構造体の製造方法 |
JP2021148618A (ja) * | 2020-03-19 | 2021-09-27 | 株式会社日本触媒 | 基材に接着されたスフェロイドを観察する方法 |
US11732232B2 (en) | 2020-08-14 | 2023-08-22 | Korea Research Institute Of Bioscience And Biotechnology | Biomimetic cell culture apparatus and cell culture system comprising the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06327462A (ja) | 1993-05-21 | 1994-11-29 | Sumitomo Bakelite Co Ltd | 細胞凝集体の形成方法 |
JP2001157574A (ja) * | 1999-11-30 | 2001-06-12 | Terumo Corp | ハニカム構造体およびその調製方法、ならびにその構造体を用いたフィルムおよび細胞培養基材 |
JP2002335949A (ja) | 2001-05-22 | 2002-11-26 | Inst Of Physical & Chemical Res | ハニカム構造体フィルムを用いた細胞の三次元組織培養法 |
JP2005027598A (ja) * | 2003-07-09 | 2005-02-03 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞培養チップ及び培養器、それらを用いた細胞培養方法、球状細胞組織体を担持させた細胞担持モジュール、球状細胞組織体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4132379A1 (de) * | 1991-09-28 | 1993-04-08 | Kernforschungsz Karlsruhe | Substrat fuer zellkulturen und kultur von zellen oder zellaggregaten |
WO1999047922A2 (en) * | 1998-03-18 | 1999-09-23 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
JP4294425B2 (ja) * | 2003-09-10 | 2009-07-15 | 独立行政法人農業・食品産業技術総合研究機構 | 細胞培養プレート |
JP2006223672A (ja) * | 2005-02-18 | 2006-08-31 | Sii Nanotechnology Inc | 生体組織構造を模倣したナノバイオデバイス |
WO2006093207A1 (ja) * | 2005-03-02 | 2006-09-08 | National University Corporation Hokkaido University | 細胞の分化/増殖を制御するための基材 |
-
2007
- 2007-02-21 KR KR1020087022920A patent/KR101362293B1/ko active IP Right Grant
- 2007-02-21 EP EP07713488.0A patent/EP1988152B1/en active Active
- 2007-02-21 US US12/280,125 patent/US7727759B2/en active Active
- 2007-02-21 JP JP2008501636A patent/JP5397934B2/ja not_active Expired - Fee Related
- 2007-02-21 JP JP2008501635A patent/JP4159103B2/ja not_active Expired - Fee Related
- 2007-02-21 WO PCT/JP2007/000107 patent/WO2007097121A1/ja active Application Filing
- 2007-02-21 WO PCT/JP2007/000106 patent/WO2007097120A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06327462A (ja) | 1993-05-21 | 1994-11-29 | Sumitomo Bakelite Co Ltd | 細胞凝集体の形成方法 |
JP2001157574A (ja) * | 1999-11-30 | 2001-06-12 | Terumo Corp | ハニカム構造体およびその調製方法、ならびにその構造体を用いたフィルムおよび細胞培養基材 |
JP2002335949A (ja) | 2001-05-22 | 2002-11-26 | Inst Of Physical & Chemical Res | ハニカム構造体フィルムを用いた細胞の三次元組織培養法 |
JP2005027598A (ja) * | 2003-07-09 | 2005-02-03 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞培養チップ及び培養器、それらを用いた細胞培養方法、球状細胞組織体を担持させた細胞担持モジュール、球状細胞組織体 |
Non-Patent Citations (3)
Title |
---|
ITO Y. ET AL.: "Nano Imprint Gijutsu no Bio Technology eno Oyo", BIO INDUSTRY, vol. 21, no. 11, 12 October 2004 (2004-10-12), pages 28 - 36, XP003017277 * |
NOMURA S. ET AL.: "Nanopillar sheets as a new type of cell culture dish: detailed study of HeLa cells cultured on nanopillar sheets", J. ARTIF. ORGANS, vol. 9, no. 2, June 2006 (2006-06-01), pages 90 - 96, XP019385839 * |
See also references of EP1988152A4 |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010022366A (ja) * | 2008-06-16 | 2010-02-04 | Scivax Kk | スフェロイド作製方法 |
JP2010017128A (ja) * | 2008-07-10 | 2010-01-28 | Toyota Central R&D Labs Inc | 培養細胞のハンドリング体、その製造方法及びその利用 |
JP2011019413A (ja) * | 2009-07-14 | 2011-02-03 | Scivax Kk | 細胞剥離抑制器具及びこれを用いた培養容器、細胞剥離抑制方法 |
JP2011050295A (ja) * | 2009-09-01 | 2011-03-17 | Scivax Kk | 細胞培養構造体、細胞培養容器及びこれらの製造方法 |
JP2013099275A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 機能性フィルムを移送するための負圧吸着ヘッドとそれを用いた機能性フィルムの移送方法 |
US9587219B2 (en) | 2011-11-08 | 2017-03-07 | Dai Nippon Printing Co., Ltd. | Method for producing cell culture vessel |
JP2013099279A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 樹脂製細胞培養容器とその製造方法 |
JP2013099278A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 細胞培養容器の製造方法 |
JP2013099287A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | ボトル型の細胞培養容器及びその製造方法 |
JP2013099285A (ja) * | 2011-11-08 | 2013-05-23 | Dainippon Printing Co Ltd | 細胞培養容器の製造方法 |
WO2013069490A1 (ja) * | 2011-11-08 | 2013-05-16 | 大日本印刷株式会社 | 細胞培養容器の製造方法 |
JP2013102737A (ja) * | 2011-11-15 | 2013-05-30 | Covalent Materials Corp | 細胞培養担体及びその製造方法 |
JP2013106529A (ja) * | 2011-11-17 | 2013-06-06 | Dainippon Printing Co Ltd | 機能性フィルムの移送装置 |
US11441121B2 (en) | 2013-04-30 | 2022-09-13 | Corning Incorporated | Spheroid cell culture article and methods thereof |
US9790465B2 (en) | 2013-04-30 | 2017-10-17 | Corning Incorporated | Spheroid cell culture well article and methods thereof |
JP2015008701A (ja) * | 2013-07-01 | 2015-01-19 | 独立行政法人理化学研究所 | 分化転換制御方法および基板 |
US11976263B2 (en) | 2014-10-29 | 2024-05-07 | Corning Incorporated | Cell culture insert |
US11613722B2 (en) | 2014-10-29 | 2023-03-28 | Corning Incorporated | Perfusion bioreactor platform |
JP2018512930A (ja) * | 2015-03-26 | 2018-05-24 | フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー.ファオ. | 人工デスメ膜 |
US11504225B2 (en) | 2015-03-26 | 2022-11-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Artificial Descemet construct |
JP2017181722A (ja) * | 2016-03-30 | 2017-10-05 | Jsr株式会社 | ラインパターン、光制御部材および光学結像部材の製造方法 |
JP2018085978A (ja) * | 2016-11-30 | 2018-06-07 | 旭硝子株式会社 | 培養容器 |
US11603515B2 (en) | 2017-03-31 | 2023-03-14 | National University Corporation Hokkaido University | Cell culture substrate, cancer cell aggregate and method for manufacturing same using said substrate, and drug screening method using said cancer cell aggregate |
US11584906B2 (en) | 2017-07-14 | 2023-02-21 | Corning Incorporated | Cell culture vessel for 3D culture and methods of culturing 3D cells |
US11767499B2 (en) | 2017-07-14 | 2023-09-26 | Corning Incorporated | Cell culture vessel |
US11857970B2 (en) | 2017-07-14 | 2024-01-02 | Corning Incorporated | Cell culture vessel |
US11970682B2 (en) | 2017-07-14 | 2024-04-30 | Corning Incorporated | 3D cell culture vessels for manual or automatic media exchange |
US11345880B2 (en) | 2017-07-14 | 2022-05-31 | Corning Incorporated | 3D cell culture vessels for manual or automatic media exchange |
US11661574B2 (en) | 2018-07-13 | 2023-05-30 | Corning Incorporated | Fluidic devices including microplates with interconnected wells |
US11732227B2 (en) | 2018-07-13 | 2023-08-22 | Corning Incorporated | Cell culture vessels with stabilizer devices |
US11912968B2 (en) | 2018-07-13 | 2024-02-27 | Corning Incorporated | Microcavity dishes with sidewall including liquid medium delivery surface |
JP7180698B2 (ja) | 2019-02-14 | 2022-11-30 | 王子ホールディングス株式会社 | 細胞シート形成部材、基材、および、細胞シート形成部材の製造方法 |
JPWO2020166279A1 (ja) * | 2019-02-14 | 2021-10-07 | 王子ホールディングス株式会社 | 細胞シート形成部材、基材、および、細胞シート形成部材の製造方法 |
WO2020166279A1 (ja) * | 2019-02-14 | 2020-08-20 | 王子ホールディングス株式会社 | 細胞シート形成部材、基材、および、細胞シート形成部材の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2007097121A1 (ja) | 2009-07-09 |
EP1988152B1 (en) | 2016-11-23 |
WO2007097121A1 (ja) | 2007-08-30 |
US7727759B2 (en) | 2010-06-01 |
KR20090004879A (ko) | 2009-01-12 |
US20090246872A1 (en) | 2009-10-01 |
KR101362293B1 (ko) | 2014-02-12 |
JP5397934B2 (ja) | 2014-01-22 |
EP1988152A1 (en) | 2008-11-05 |
JP4159103B2 (ja) | 2008-10-01 |
JPWO2007097120A1 (ja) | 2009-07-09 |
EP1988152A4 (en) | 2010-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007097120A1 (ja) | 細胞培養構造体、細胞培養容器、スフェロイド付き構造体、スフェロイド付き容器およびこれらの製造方法 | |
Ramón-Azcón et al. | Gelatin methacrylate as a promising hydrogel for 3D microscale organization and proliferation of dielectrophoretically patterned cells | |
Lin et al. | Dielectrophoresis based‐cell patterning for tissue engineering | |
Bucaro et al. | Fine-tuning the degree of stem cell polarization and alignment on ordered arrays of high-aspect-ratio nanopillars | |
Nawroth et al. | Automated fabrication of photopatterned gelatin hydrogels for organ-on-chips applications | |
Wang et al. | Efficient capture of cancer cells by their replicated surfaces reveals multiscale topographic interactions coupled with molecular recognition | |
Pasirayi et al. | Microfluidic bioreactors for cell culturing: a review | |
Kumar | Microfluidic devices in nanotechnology: applications | |
CN103421691B (zh) | 一种基于微流体构图技术的单细胞阵列培养玻璃芯片及其制备方法 | |
JP2008054521A (ja) | 細胞培養処理装置及び細胞培養処理方法 | |
Sun et al. | A novel three-dimensional microfluidic platform for on chip multicellular tumor spheroid formation and culture | |
CN104039951B (zh) | 用于引导细胞迁移的装置和实施这种装置的引导方法 | |
JP2012249547A (ja) | 細胞培養用基材及びその製造方法 | |
Pensabene et al. | Ultrathin polymer membranes with patterned, micrometric pores for organs-on-chips | |
Yang et al. | Recent advance in cell patterning techniques: Approaches, applications and future prospects | |
Farshidfar et al. | The feasible application of microfluidic tissue/organ-on-a-chip as an impersonator of oral tissues and organs: a direction for future research | |
Agarwal et al. | Dielectrophoresis-based devices for cell patterning | |
Homhuan et al. | Single-cell electroporation using proton beam fabricated biochips | |
Xu et al. | Force-sensing micropillar arrays for cell mechanics and mechanobiology | |
JP5894732B2 (ja) | 細胞培養基材の評価方法 | |
Ziółkowska et al. | Novel designs and technologies for cell engineering | |
JP6326915B2 (ja) | 細胞培養基材 | |
Cai et al. | Recent advances in optically induced di-electrophoresis and its biomedical applications | |
US9939353B2 (en) | Apparatus for cell observation and method for cell collection using the same | |
Ahmed et al. | Rapid prototyping of PMMA-based microfluidic spheroid-on-a-chip models using micromilling and vapour-assisted thermal bonding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2008501635 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2007713488 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007713488 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087022920 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12280125 Country of ref document: US |